Identification of matrix metalloproteinases in canine neoplastic tissue

American Journal of Veterinary Research

Volumn 61, Issue 2, 2000, Pages 111-114

  Lana, Susan E ^a   Ogilvie, Gregory K ^a   Hansen, Rodney A ^a   Powers, Barbara E ^a   Dernell, William S ^a   Withrow, Stephen J ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

GELATINASE A; GELATINASE B;

ANIMAL; ANIMAL DISEASE; ARTICLE; BONE TUMOR; COMPARATIVE STUDY; DOG; DOG DISEASE; ENZYMOLOGY; HUMAN; METABOLISM; OSTEOSARCOMA; STROMA CELL;

ANIMALS; BONE NEOPLASMS; DOG DISEASES; DOGS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OSTEOSARCOMA; STROMAL CELLS;

EID: 0034132643     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2000.61.111     Document Type: Article

References (23)

1. Beckett RP, Davidson AH, Drummond AH, et al. Recent advances in matrix metalloproteinase inhibitor research. Drug Discov Today 1996;1:16-26.
2. Durko M, Brodt P. The metalloproteinases and their inhibitors. In: Brodt P, ed. Cell adhesion and invasion in cancer metastasis. R.G. Landes Co, 1996;113-150.
3. Cawston T.E. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther 1996;70:163-182.
4. Wojtowicz-Praga SM, Dickson RB, Hawkins MJ. Matrix metalloproteinase inhibitors. Inves New Drugs 1997;15:61-75.
5. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis:an imbalance of positive and negative regulation. Cell 1991;64:327-336.
6. MacDougall JR, Martisian I.M. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion, and metastasis. Cancer Metastasis Rev 1995;14:351-362.
7. Davies B, Miles DW, Happerfield LC, et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 1993;67:1126-1131.
8. Stearns ME, Stearns M. Immunohistochemical studies of activated matrix metalloproteinase-2 (MMP-2a) expression in human prostate cancer. Oncol Res 1996;8:63-67.
9. Montironi R, Lucarini G, Castaldini C, et al. Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia. Anticancer Research 1996;16:2057-2062.
10. Sier CFM, Kubben FJGM, Ganesh S, et al. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 1996;74:413-417.
11. Newell KJ, Witty JP, Rodgers WH, et al. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 1994;10:199-206.
12. Grignon DJ, Sakr W, Toth M, et al. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res 1996;56: 1654-1659.
13. Low JA, Johnson MD, Bone EA, et al. The matrix metalloproteinase inhibitor Batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice. Clin Cancer Res 1996;2:1207-1214.
14. Anderson IC, Shipp MA, Docherty AJP, et al. Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine lewis lung carcinoma. Cancer Res 1996;56:715-718.
15. Watson SA, Morris TM, Parsons SL, et al. Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model. Br J Cancer 1996;74:1354-1358.
16. An Z , Wang X , Willmott W , et al. Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor. Clin Exp Metastasis, 1997;15:184-195.
17. Opdenakker G, Van Damme J. Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. Cytokine 1992; 4:251-258.
18. Withrow SJ, Powers BE, Straw RC, et al. Comparative aspects of osteosarcoma: dog versus man. Clin Orthop 1991;270:159-167.
19. Spodnick GJ, Berg J, Rand WM, et al. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). J Am Vet Med Assoc 1992;200:995-999.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72:248, 1976.
21. Huessen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecylsulfate and copolymerized substartes. Anal Biochem 1980;102:196-202.
22. Sang QA, Douglas DA. Computational sequence analysis of matrix metalloproteinases. J Protein Chem 1996;15:137-160.
23. Coughlan AR, Robertson DHL, Burke R, et al. Isolation and identification of canine matrix metalloproteinase-2 (MMP-2). Vet J 1998;155:231-237.